Julia Lipovetzky; Mariana Arias; Alejandra Abeldaño

Authors

Julia Lipovetzky General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
Mariana Arias General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
Alejandra Abeldaño General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Keywords:

adult T-cell leukemia/lymphoma, ATLL, human T-cell lymphotropic virus type 1, HTLV1, cutaneous T-cell lymphomas

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a mature T lymphocyte neoplasm that is associated with human T-cell lymphotropic virus type 1 (HTLV1). It is very aggressive, with a short survival in most cases, and is resistant to chemotherapy. In skin it has no characteristic lesions, it usually mimics cutaneous T-cell lymphomas (CTCL) or other dermatoses, and is affected in 43-72% of cases. In Argentina, especially Buenos Aires, it must be considered an emerging pathology due to the increased circulation of the virus by immigration from endemic places.

Author Biographies

Julia Lipovetzky, General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Medical Dermatologist Attached

Mariana Arias, General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Staff Dermatologist

Alejandra Abeldaño, General Acute Hospital Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Head of Unit

References

I. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, et ál. Adult T-ce-ll leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-492.

II. Bittencourt AL, Paim de Oliveira M. Cutaneous manifes-tations associated with HTLV-1 infection. Int J Dermatol2010;49:1099-1110.

III. Cerrutti M. La migración peruana a la Ciudad de Buenos Ai-res: su evolución y características. Población de Buenos Aires. 2005. Vol 2. <https://www.researchgate.net/profile/Marce-la_Cerrutti/publication/242620392_La_migracion_perua-na_a_la_Ciudad_de_Buenos_Aires_su_evolucion_y_carac-tersticas/links/54ec4ef70cf27fbfd76f41c8.pdf> Consultado el 3 de marzo de 2016. ISSN 1668-5458.

IV. Gotuzzo E, Verdonck K, González E, Cabada M. Virus lin-fotrópico humano de células T tipo 1 (HTLV-1): una infec-ción endémica en el Perú. Rev Peru Med Exp Salud Pública2004;21:253-260.

V. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, et ál. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lym-phoma. P Natl Acad Sci USA 1980;70:7415-7419.

VI. Vásquez P. HTLV-1 (Human T-cell lymphotropic virus), algo que decir? Rev Chil Infect 2003;20:34-37.

VII. Biglione MM, Berini CA. Aportes y consideraciones sobre la infección por los virus linfotrópicos-T humanos tipo 1 y 2 en Argentina. Actual SIDA Infectol 2013;21:84-94.

VIII. Bangham CRM, Ratner L. How does HTLV-1 cause adult T-cell leukemia/lymphoma (ATL)? Curr Op Virol 2015;14:93-100.

IX. Kress AK, Grassman R, Fleckenstein B. Cell surface markers in HTLV-1 pathogenesis. Viruses 2011;3:1439-1459.

X. Tsuda T, Ishiwaka M, Banno T, Fujisawa S, et ál. A case of adult T-cell leukemia/lymphoma with an indolent clinical course has an unusual proviral DNA integration pattern. Acta Derm Venereol 2003;83:139-140.

XI. Tokura Y, Sawada Y, Shimauchi T. Skin manifestations of adult T-cell leukemia/lymphoma: Clinical, cytological and immu-nological features. J Dermatol 2014;41:19-25.

XII. Ishida T, Utsunoyima A, Iida S, Inagaki H, et ál. Clinical signi-ficance of CCR4 expression in adult T-cell leukemia/lympho-ma: its close association with skin involvement and unfavora-ble outcome. Clin Cancer Res 2003;9:3625-3634.

XIII. Sugita K, Shimauchi T, Kabashima R, Nakasshima D, et ál. Loss of CCR4 expression upon leukemic change in adult T-cell leu-kemia/lymphoma. J Am Acad Dermatol 2009;61:163-164.

XIV. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 2005;24:6058-6068.

XV. Moreno C, Balangero M, Barbás MG, Cudolá A, et ál. Diagnós-tico serológico de HTLV-1/2: combinación de técnicas de ta-mizaje para definir estatus serológico en donantes de sangre. Rev Arg Microbiol 2013;45. http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000300006> Consultado el 3 de marzo de 2016; ISSN 0325-7541.

XVI. Gallego S, Mangano A, Gastaldello R, Sen L, et ál. Usefulness of a nested-polymerase chain reaction for molecular diag-nosis of human T-cell lymphotropic virus type I/II. Mem Inst Oswaldo Cruz 2004;99:377-380.

XVII. Ishikara K, Inokuchi N, Tsushima Y, Tsuruda K, et ál. Relevance of molecular tests for HTLV-1 infection as a confirmatory tests after the first sero-screening. J Immunoassay Immunochem2014;35:74-82.

XVIII. Yamaguchi T, Ohshima K, Karube K, Yutiya T, et ál. Clinicopa-thological features of cutaneous lesions of adult T-cell leuke-mia/lymphoma. Br J Dermatol 2005;152:76-81.

XIX. Gastaldello R, Hall WW, Gallego S. Seroepidemiology of HTLV-I/II in Argentina: an overview. J Acquir ImmuneDefic Sy-ndr 2004;35:301-308.

XX. Gessain A, Cassar O. Epidemiological aspects and world dis-tribution of HTLV-1 infection. Front Microbiol 2012;3:1-23.

XXI. Eirin M, Bravi C, Jones L, Berini C, et ál. Ethnic/geographic analy-sis of human T-cell lymphotropic virus type 1 (HTLV-1) infection among Buenos Aires residents in Argentina. Retrovir 2011;8:88.

XXII. Yazdanpanah MJ, Maleki M, Joneidi N, Khalighi AR, et ál. Cu-taneous manifestations in HTLV-1 positive blood donors. Iran J Basic Med Sci 2013;16:273-277.

XXIII. Sibon D, Cassar O, Duga I, Brouzes C, et ál. Adult T-cell leuke-mia/lymphoma in a Caucasian patient after sexual transmis-sion of human T-cell lymphotropic virus type 1. Open Forum Infect Dis 2015;2:1-5.

XIV. Shimoyama M. Diagnostic criteria and classification of clini-cal subtypes of adult T-cell leukaemia/lymphoma. Br J Hae-matol 1991;79:428-487.

XV. Marchetti MA, Pulitzer MP, Myskowski PL, Dusza SW, et ál. Cu-taneous manifestations of human T cell lymphotropic virus ty-pe-1-associated adult T-cell leukemia/lymphoma: A single-cen-ter retrospective study. J Am Acad Dermatol 2015;72:293-301.

XVI. Lucas CT, Gillisn K, Ness JM, Hammers YA, et ál. Adult T-cell leukemia/lymphoma in an adolescent presenting with skin lesions. Pediatr Dermatol 2008; 25:373-377.

XVII. Do Valle ACF, Galhardo MC, Leite ACC, Araújo AQC, et ál. Adult T-cell leukemia/lymphoma associated with HTLV-1 infection in a brazilian adolescent. Rev Inst Med trop S Paulo2001;43:283-286.

XVIII. Gioseffi ON, Nucifora E, Fanti D, Doufour C, et ál. Adult HTLV-1 positive leukemia-lymphoma in Argentina. Sangre 1995;40:421-424.

XIX. Prates V, Cobos M, Bouzas B, Napal J, et ál. The first report of familial adult T-cell leukemia/lymphoma in Argentina. Leuk Lymphoma 2000;37:225-227.

XXX. Marin O, Hasui K, Remondegui C, Sat E, et ál. Adult T-cell leu-kemia/lymphoma in Jujuy, north-west Argentina. Pathol Int2002;52: 348-357.

XXXI. Mangano A, Saliba Pineda M, Costantini P, Bouzas MB, et ál. HTLV-1 proviral load in adult T-cell leukemia/lymphoma (ATLL) patients from non-endemic regions of Argentina. Re-trovir 2014;11:34.

XXXII. Kaminsky A, Díaz M, Ryb M, Lagioia R, et ál. Virus de la leu-cemia T humana (HTLV-1). Linfoma/leucemia de células T del adulto. Presentación de un caso. Dermatol Argent 2003;9:295-300.

XXXIII. Forero O, Villoldo MS, Pastore F, Graciano S, et ál. Leucemia/linfoma de células T del adulto: HTLV-1 positivo. A propósito de un caso. Arch Argent Dermatol 2006;56:137-141.

XXXIV. Bittencourt AL, Vieira M, Brites CR, Farre L, et ál. Adult T-cell leu-kemia/lymphoma in Bahia, Brazil. Analysis of prognostic fac-tors in a group of 70 patients. Am J Clin Pathol 2007;128:875-882.

XXXV. Amano M, Kurokawa M, Ogta K, Itoh H, et ál. New entity, defi-nition and diagnostic criteria of cutaneous adult T-cell leuke-mia/lymphoma: Human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smolde-ring types. J Dermatol 2008;35:270-275.

XXXVI. Setoyama M, Katahira Y, Kanzaki T. Clinicopathologic analysis of 124 cases of adult T-cell leukemia/lymphoma with cuta-neous manifestations: the smouldering type with skin mani-festations has a poorer prognosis than previously thought. J Dermatol 1999;26:785-790.

XXXVII. Yagi H, Takigawa M, Hashizume H. Cutaneous type of adult T cell leukemia/lymphoma: a new entity among cutaneous lymphomas. J Dermatol 2003;30:641-643.

XXXVIII. Ocampo Lyra-da-Silva J, Mello Gonzaga YB, De Melo Espín-dola O, Andrada-Serpa MJ, et ál. Adult T-cell leukemia/lym-phoma: a case report of primary cutaneous tumoral type. Dermatol Pract Concept 2012;2:9-13.

XXXXIX. Chan H, Su I, Kuo T, Kuan Y, et ál. Cutaneous manifestations of adult T-cell leukemia/lymphoma. J Am AcadDermatol1985;13:213-219.

XL. Okada J, Imafuku S, Tsujita J, Moroi Y, et ál. Case of adult T-cell leukemia-lymphoma manifesting marked purpura. J Derma-tol 2007;34:782-785.

XLI. Pezeshkpoor F, Yazdanpanah MJ, Shirdel A. Specific cuta-neous manifestations in adult T-cell leukemia/lymphoma. Int J Dermatol 2008;47:359-362.

XLII. Sakamoto FH, Colleoni GWB, Teixeira SP, Yamamoto M, et ál.Cutaneous T-cell lymphoma with HTLV-1 infection: clinical overlap with adult T-cell leukemia/lymphoma. Int J Dermatol2006;45:447-449.

XLIII. Setoyama M, Yamamoto S, Kanzaki T. Adult T-cell leukemia/lymphoma presenting with digital gangrene. Dermatol 1997;195:150-152.

XLIV. Kawakami T, Kawanabe T, Soma Y. Granuloma annulare-like skin lesions as an initial manifestation in a Japanese patient with adult T-cell leukemia/lymphoma. J Am Acad Dermatol2009;60:848-852.

XLV. Shimizu S, Yasui C, Koizumi K, Ikeda H, et ál. Cutaneous-ty-pe adult T-cell leukemia/lymphoma presenting as a solitary skin nodule: A review of the literature. J Am Acad Dermatol2007;57:115-117.

XLVI. Bégon E, Blum L, Benramdane R, Leroux C, et ál. Oral mani-festation of Adult T-cell leukemia/lymphoma. Arch Dermatol 2010;146:804-805.

XLVII. Bittencourt AL, Barbosa HS, Vieira M, Farré L. Adult T-cell leu-kemia/lymphoma (ATL) presenting in the skin: clinical, histo-logical and immunohistochemical features of 52 cases. Acta Oncol 2009;48:598-604.

XLVIII. Brito Santos J, Farré L, Da Silva Batista E, Santos HH, et ál. The importance of flower cells for the early diagnosis of acute adult T-cell leukemia/lymphoma with skin involvement. Acta Oncol 2010;49:265-267.

XLIX. Othake N, Setoyama M, Fukumaru S, Kanzaki T. A case of adult T cell leukemia/lymphoma (ATLL) with angiocentric and angiodestructive features. J Dermatol 1997;24:165-169.

L. Camp B, Horwitz Y, Pulitzer M. Adult T-cell leukemia/lympho-ma with follicular mucinosis: an unusual histopathological finding and a commentary. J Cutan Pathol 2012;39:861-865.

LI. Ishida M, Iwai M, Yoshida K, Kagotani A, et ál. Adult T-cell leukemia/lymphoma accompanying follicular mucinosis: a case report with review of the literature. Int J Clin Exp Pathol2013;6:3014-3018.

LII. Setoyama M, Katahira Y, Kanzaki T, Kerdel, et ál. Adult T-cell leukemia/lymphoma with non infectious epithelioid granu-loma in the skin: a clinicopathologic study. Am J Dermopath1997;19:591-595.

LIII. Kim NH, Torchia D, Miteva M, Rongioletti F, et ál. Prominent apoptosis in Pautrier microabscesses: a distinctive finding in adult T-cell leukemia/lymphoma? Am J Dermatopath2011;33:530-531.

LIV. Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, et ál. Expres-sion of FoxP3, a key molecule in CD4+CD25+ regulatory T cells, in adult T-cell leukemia/lymphoma cells. Br J Haematol 2004;126:81-84.

LV. Miyata T, Yonekura K, Utsunomiya A, Kanekura T, et ál. Cu-taneous Adult T-cell leukemia/lymphoma is a characteristic subtype and includes erythema/papule and nodule/tumor subgroups. Int J Cancer 2010;126:1521-1528.

LVI. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, et ál. Defini-tion, prognostic factors, treatment and response criteria of adult T-cell leukemia-lymphoma: a proposal from an interna-tional consensus meeting. J Clin Oncol 2009;27:453-459.

LVII. Kawai K, Uchida Y, Yonekura K, Virtanen S, et ál. Cutaneous-ty-pe adult T-cell leukemia/lymphoma does not primarily show deletion of NAV3 gene. J Invest Dermatol 2010;130:316-318.

LVIII. Bazarbachi A, Plumelle Y, Ramos JC, Tortevoye P, et ál. Me-ta-analysis of the use of zidovudine and interferon-alfa in in adult T-cell leukemia/lymphoma showing improved survival in leukemic types. J Clin Oncol 2010;28:4177-4183.

LIX. Sawada Y, Hino R, Hama K, Ohmori S, et ál. Type of skin erup-tion is an independent prognostic indicator for adult T-cell leu-kemia/lymphoma. Blood 2011;117:3961-3967.

LX. Olivares L, D ́Atri G, Martinetti C, Ciccia L, et ál. Dermatitis infectiva asociada a HTLV-1, en un adulto. Dermatol Argent2009;15:49-53.

LXI. Díaz CJ, Valencia M. Manifestaciones cutáneas asociadas con el HTLV-1. Rev Asoc Colomb Dermatol 2011;22:67-73.

LXII. Uozumi K. Treatment of adult T-cell leukemia. J Clin Exp Hae-matopathol 2010;50:9-25.

LXIII. Tsukasaki K, Utsunoyima A, Fukuda H, Shibata T, et ál. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol. 2007; 25: 5458-5464.

LXIV. Hermine O, Bouscary D, Gessain A, Turlure V, et ál. Brief report: treatment of Adult T-cell leukemia/lymphoma with zidovudi-ne and interferon alfa. N Engl J Med 1995;332:1749-1751.

LXV. Takemori N, Hirai K, Onoderea R, Saito N, et ál. Satisfactory remis-sion achieved by PUVA therapy in a case of crisis-type adult T-ce-ll leukemia/lymphoma with generalized cutaneous leukaemic cell infiltration. Br J Dermatol 1995;133:955-960(Abstract).

LXVI. Itonaga H, Tsushima JT, Fukushima T, Taniguchi H, et ál. Treat-ment of relapsed adult T-cell leukemia/lymphoma after allo-geneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013;121:219-225.

LXVII. Ishida T, Joh T, Uike N, Yamamoto K, et ál. Defucosylated an-ti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia/lymphoma: a multicenter phase II study. J Clin Oncol 2012;30:837-842.

LXVIII. Idhida T, Jo T, Takemoto S, Suzushima H, et ál. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lympho-ma: a randomized phase II study. Br J Dermatol 2015;169:672-682.

LXIX. Waldmann TA, White JD, Goldman CK, Top L, et ál. The interleu-kin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus 1- induced adult T-cell leuke-mia. Blood 1993;82:1701-1712.

LXX. Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, et ál. Low-dose bexaroteno and low-dose interferon alfa-2b for in adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1. Arch Dermatol 2005;141:301-304.

LXXI. Plumelle Y, Michel S, Banydeen R, Delaunay C, et ál. Characte-ristics of adult T-cell leukemia-lymphoma patients with long survival: prognostic significance of skin lesions and possible beneficial role of valproic acid. Leuk Res Treatment 2015. Vol 2015. < http://www.hindawi.com/journals/lrt/2015/476805/> Consultado el 13 de diciembre de 2015; ISSN 2090-3219

LXXII. Ishitzuka K, Utsunomiya A, Katsuya H, Takeuchi S, et ál. A pha-se II study of bortezomib in patients with relapsed or refrac-tory aggressive adult T-cell leukemia/lymphoma. Cancer Sci2015;106:1219-1223.

LXXIII. Simone CB, Morris JC, Stewart DM, Urquhart NE, et ál. Radiation therapy for management of patients with HTLV-1 associated adult T-cell leukemia/lymphoma. Blood 2012;120:1816-1819.